Clinical Trial

Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program

Recruiting
View on ClinicalTrials.gov →
Summary
Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and ACEs. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the Strengthening Families Program (SFP) + Family Advocate (FA) intervention on substance use, overdose, and ACEs in 18 communities compared with SFP-only in 18 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for Implementation Research (CFIR) to explore implementation barriers and facilitators; and (3) conduct a cost evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help disproportionately affected communities prevent substance use, overdose, and ACEs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-23; most recent amendment 2026-04-29.
Trial Details
NCT Number NCT06236100
Lead Sponsor RTI International
Collaborators: New Jersey Prevention Network, RWJBarnabas Health Institute for Prevention and Recovery
Conditions Substance-Related Disorders, Adverse Childhood Experiences
Enrollment 360 participants
Start Date 2023-11-29
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-09-29 (estimated)
Updated on ClinicalTrials.gov 2026-05-05